Danicopan
Complement Inhibitors
Sold as VOYDEYA
- Drug class
- Complement Inhibitors
- Availability
- See label
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 5
Overview
Danicopan is an active pharmaceutical ingredient in the Complement Inhibitors group (L04AJ). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 2 | May 22, 2026 |
| CA Canada | Health Canada | 2 | December 31, 2025 |
| EU European Union | EMA | 1 | January 13, 2026 |
GBUnited Kingdom· MHRA
2 products
Uses
1).
How to take
CACanada· Health Canada
2 products
How to take
2 Recommended Dose and Dosage Adjustment 10/2025 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed. RECENT MAJOR LABEL CHANGES ..........................................................................................
2 Part 1: Healthcare Professional Information.......................................................................... 4 1 Indications ................................................................................................................
1 Pediatrics................................................................................................................ 2 Geriatrics ................................................................................................................
4 2 Contraindications ...................................................................................................... 4 3 Serious Warnings and Precautions Box ......................................................................
EUEuropean Union· EMA
1 product
Uses
1).
How to take
Sources & citations
- [1]MHRA (UK) · PLGB311870023 · revised May 22, 2026
- [2]Health Canada (DPD) · 02550040 · revised December 31, 2025
- [3]European Medicines Agency · EMEA/H/C/005517 · revised January 13, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.